SBC
SBC Medical Group Holdings Incorporated4.1000
+0.0100+0.24%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
420.57MP/E (TTM)
9.76Basic EPS (TTM)
0.42Dividend Yield
0%Recent Filings
8-K
8-K
10-Q
Q2 FY2025 results
SBC Medical Group Holdings posted Q2 FY2025 revenue of $43.4M, down 18% y/y but up 10% q/q (derived), as fee revisions for franchising and management services trimmed topline gains, while rental and procurement streams grew on new clinic demand and equipment upgrades. Gross margins held at 69%, with operating income at $14.6M versus $27.3M y/y, pressured by higher consulting fees tied to Nasdaq listing. Diluted EPS of $0.02 aligns with 103.5M shares, reflecting a $9.7M deemed contribution from aircraft sale adjustment boosting equity. Cash swelled to $152.7M, up 22% q/q, with $7.1M low-rate debt and ample revolver headroom; free cash flow not disclosed in the 10-Q. Yet competition from rival aesthetics chains could squeeze margins further.
8-K
Q2 revenues drop 18% to $43M
SBC Medical Group Holdings reported Q2 2025 revenues of $43 million, down 18% year-over-year, hit by staffing business discontinuation, divestitures, and fee revisions—yet franchise locations swelled to 259, up 36, while customer visits hit 6.31 million, up 14%. Net income plunged 87% to $2.5 million, with EBITDA at $15 million and a 35% margin, reflecting strategic pivots amid Japan's cautious spending. Operations remain robust. Forward-looking confidence centers on franchise optimization and higher-margin shifts.
8-K
SBC acquires Japanese clinic network
SBC Medical Group Holdings acquired MB Career Lounge on July 17, 2025, via a cash share purchase funded by a bank loan, bringing JUN CLINIC's network into its portfolio. This move diversifies services across aesthetic dermatology and plastic surgery in Japan, tapping into a ¥631 billion market that grew 6.2% last year. Acquisition bolsters revenue stability. Yet integration risks loom amid market uncertainties.
AIRS
AirSculpt Technologies, Inc.
2.57-0.06
BMGL
Basel Medical Group Ltd
0.76-0.10
DFCO
Dalrada Financial Corp.
0.04-0.00
EGG
Enigmatig Limited
3.80+0.20
HCSG
Healthcare Services Group, Inc.
19.09-0.27
HURN
Huron Consulting Group Inc.
179.14+0.74
PAIYY
Aesthetic Medical International
0.13+0.00
RMTG
Regenerative Medical Technology
0.04+0.00
SSHT
SSHT S&T Group Ltd.
0.04-0.01
YJGJ
Yijia Group Corp.
1.61+0.00